Brief: Venbio Global Strategic Fund III Reports 8.03% Stake In Elevation Oncology Inc
27/05/2022 23:18
May 27 (Reuters) - Elevation Oncology Inc ELEV.O :
* VENBIO GLOBAL STRATEGIC FUND III, L.P. REPORTS 8.03% STAKE
IN
ELEVATION ONCOLOGY INC AS OF MAY 25 - SEC FILING
* VENBIO GLOBAL STRATEGIC FUND III, L.P. - HAD PREVIOUSLY
REPORTED
11.43% STAKE IN ELEVATION ONCOLOGY INC AS OF JUNE 29, 2021
Further company coverage: ELEV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing